NDAINHALATIONGAS
Approved
Apr 2018
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
3/8 — Basic
NITROGEN, NF (nitrogen) by Advanced Solutions Life Sciences. Approved for critical illness, postoperative complications, nutrition therapy and 6 more indications. First approved in 2018.
Drug data last refreshed 22h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Nitrogen, NF is an inhaled gas product approved in 2018 for use in critical illness, postoperative complications, nutrition therapy, and various other indications including gastrointestinal neoplasms, superficial basal cell carcinoma, and bronchopulmonary dysplasia. The product operates as a pharmaceutical gas without a defined mechanism of action or pharmacologic class. It represents a niche therapeutic modality with multiple acute and chronic care applications.
Peak
Product is at peak lifecycle stage with moderate competitive pressure (30%), but limited commercial data suggests a specialized market with smaller team requirements than mainstream therapeutics.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on NITROGEN, NF at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.